← Back to Search

ePROMs + Information Hub for Chronic Kidney Failure

N/A
Recruiting
Led By Istvan Mucsi
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing maintenance hemodialysis for more than 3 months
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow-up (every 4 weeks, up to 6 months)
Awards & highlights

Study Summary

This trial is looking at whether or not electronic patient reported outcome measures (ePROMs) can help assess and monitor symptoms for patients on maintenance hemodialysis, as well as whether or not a self-management support and decision support information hub can help with symptom management.

Who is the study for?
This trial is for patients who have been on maintenance hemodialysis for over 3 months due to kidney disease. It's not suitable for those with severe acute illnesses, non-English speakers, a life expectancy under 6 months, dementia, or an inability to consent.Check my eligibility
What is being tested?
The study tests SUPPORT-DIALYSIS with access to a symptom management website against standard care without this tool. Patients at two dialysis centers will be randomly assigned to either use the ePROMs and information hub or receive the usual treatment.See study design
What are the potential side effects?
Since this trial involves electronic monitoring and informational support rather than medication, traditional side effects are not expected. However, there may be indirect effects related to using technology such as stress or frustration.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been on hemodialysis for over 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow-up (every 4 weeks, up to 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and follow-up (every 4 weeks, up to 6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of Eligible Patients who decline consent
Proportion of Enrolled Patients who Drop-Out From the Study
Proportion of Participants who miss or refuse ePROMs follow-ups
+1 more
Secondary outcome measures
Clinical Team Acceptability
Patient Acceptability
Other outcome measures
Incidence Rate of Healthcare Use
Disease
Mental Health Component Score
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: SUPPORT-DIALYSIS with Access to Output Report and Information HubExperimental Treatment1 Intervention
Feasibility of SUPPORT-Dialysis at Toronto General Hospital
Group II: SUPPORT-DIALYSIS OnlyExperimental Treatment1 Intervention
Usual Treatment at Humber River Hospital

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,456 Previous Clinical Trials
482,843 Total Patients Enrolled
Humber River HospitalOTHER
5 Previous Clinical Trials
4,341 Total Patients Enrolled
Istvan MucsiPrincipal InvestigatorUniversity Health Network, Toronto
1 Previous Clinical Trials
227 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to join this investigation?

"Contrary to what is reported on clinicaltrials.gov, this medical trial is not accepting participants at the current time. Initially posted back in September 1st 2022, it was last updated a month later and has since ceased recruiting altogether. Nevertheless, there are 586 other trials that remain open for enrollment today."

Answered by AI
Recent research and studies
~16 spots leftby Mar 2025